Clinical Stage: Phase III
Russia’s potential COVID-19 vaccine, Sputnik V, is under Phase III trials. Gamaleya Research Institute — a part of Russia’s Health Ministry — is testing the virus on over 40,000 people. Several scientists across the world have been criticizing Russia over safety concerns.
On September 8, the Russian government sought India’s help in manufacturing the Sputnik V vaccine and also to conduct Phase III trials in India.
